The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome
Multiple sclerosis (MS) is a clinically heterogenous disease. Currently, we cannot identify patients with more active disease who may potentially benefit from earlier interventions. Previous data from our lab identified the CXCL13 index (I<sub>CXCL13</sub>), a measure of intrathecal prod...
Main Authors: | Steven C. Pike, Francesca Gilli, Andrew R. Pachner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/11050 |
Similar Items
-
بررسی ارتباط سطح سرمی 25- هیدروکسی ویتامین D3 با نوع تظاهر بالینی اولین حملهی دمیلینیتو عصبی
by: Zahra Nasr, et al.
Published: (2018-04-01) -
Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis
by: Pavel Hradilek, et al.
Published: (2023-03-01) -
Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review)
by: M. A. Omarova, et al.
Published: (2022-08-01) -
The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy
by: Andrew Pachner
Published: (2022-08-01) -
A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis
by: Nadia Barizzone, et al.
Published: (2022-08-01)